MEDINDIA

Search Medindia

Lpath Withdraws From Pfizer's Process to Assign iSONEP Rights

Thursday, December 12, 2013 Corporate News

CONTACT:

Scott R. Pancoast

President and CEO

Lpath, Inc.

858-926-3200

[email protected] 

INVESTOR CONTACTS:

Westwicke Partners, LLC

Stefan Loren, Ph.D.

Robert H. Uhl

Managing Director

Managing Director

(443) 213-0507

(858) 356-5932

[email protected] 

[email protected]

Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

⬆ï¸
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close